Jan Josef Stepan

Prof. Dr. Jan Josef Stepan

First Faculty of Medicine, Charles University, Prague, Czech Republic
+1
orcid

Research Focus & Metrics

Academic Career Length

62Years (1965-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2000 in Osteoporosis International
Verified
Journal Article
Closed access
PDF file
PDP. D. Delmas
P. D. Delmas
RER. Eastell
R. Eastell
PGP. Garnero
P. Garnero
MSM. J. Seibel
M. J. Seibel
JSJan Josef Stepan
Jan Josef Stepan

1 January 2001 in Breast Cancer Research and Treatment
Verified
Journal Article
Closed access
PDF file
JCJane A Cauley
Jane A Cauley
LNLarry Norton
Larry Norton
MLMarc E. Lippman
Marc E. Lippman
SEStephen Eckert
Stephen Eckert
KKKathryn A. Krueger
Kathryn A. Krueger
VJV. Craig Jordan
V. Craig Jordan

1 April 1999 in Osteoporosis International
Verified
Journal Article
Closed access
PDF file
HPH A Pols
H A Pols
DFD Felsenberg
D Felsenberg
DHD A Hanley
D A Hanley
JSJan Josef Stepan
Jan Josef Stepan
MMManuel Muñoz-Torres
Manuel Muñoz-Torres
BSB Stych
B Stych

1 September 1989 in The Journal of Clinical Endocrinology & Metabolism
Verified
Journal Article
Closed access
PDF file
JSJan Josef Stepan
Jan Josef Stepan
MLMiloš Lachman
Miloš Lachman
JZJan Zvěřina
Jan Zvěřina
VPVladímir Pacovský
Vladímir Pacovský
DBDavid J. Baylink
David J. Baylink
To test the hypothesis that the reduction in gonadal function can lead to bone mass loss, a group of 12 men who had undergone bilateral orchidectomy at the age of 28.2+−6.8 yr was evaluated. A progressive loss of the lumbar bone density was observed as a function of time after orchidectomy. Both the biochemical indices of bone resorption (urinary hydroxyproline/creatinine ratio and plasma tartrate-resistant acid phosphatase) and bone formation (serum osteocalcin and bone isoenzyme of alkaline phosphatase) were significantly increased in the patients compared with healthy controls. A positive correlation was found between urinary hydroxyproline excretion and percent change in spinal bone mineral density per yr. Because of this increase in the biochemically indicated bone resorption, nine of the patients were studied again after 1-3 yr and were thereafter treated with intranasal calcitonin. Urinary hydroxyproline excretion normalized after 3 months of treatment, and a significant decrease, but not to normal levels, was also observed in the mean values for the other biochemical indices of bone remodeling. Thus, testosterone deficiency, like estrogen deficiency, is associated with accelerated bone loss. The increase in osteoresorption was partially corrected by calcitonin treatment.

21 March 2012 in Osteoporosis International
Verified
Journal Article
Closed access
PDF file
JGJoint IOF-ECTS GIO Guidelines Working Group
Joint IOF-ECTS GIO Guidelines Working Group
SLS. Lekamwasam
S. Lekamwasam
JAJ. D. Adachi
J. D. Adachi
DAD. Agnusdei
D. Agnusdei
JBJ. Bilezikian
J. Bilezikian
JCJ. E. Compston
J. E. Compston

11 October 2004 in Archives of internal medicine (1960)
Verified
Journal Article
Closed access
PDF file
RLRobert Lindsay
Robert Lindsay
WSWim H. Scheele
Wim H. Scheele
RNRobert Neer
Robert Neer
GPGerhardt Pohl
Gerhardt Pohl
SASilvano Adami
Silvano Adami
BMBruce H. Mitlak
Bruce H. Mitlak
Research from JAMA Internal Medicine — Sustained Vertebral Fracture Risk Reduction After Withdrawal of Teriparatide in Postmenopausal Women With Osteoporosis